Antioxidant Potential of New Pyrazoline Derivatives to Prevent Oxidative Damage

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 2, 2009, Pages 107-112

  Martins, Daniele M ^a   Torres, Bruna G ^a   Spohr, Patrícia R ^a   MacHado, Pablo ^a   Bonacorso, Helio G ^a   Zanatta, Nilo ^a   Martins, Marcos A P ^a   Emanuelli, Tatiana ^a,b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b University of Santa Maria   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 5 HYDROXY 3 METHYL 5 TRIFLUOROMETHYL 4,5 DIHYDRO 1H 1 (2 HYDROXYBENZOYL)PYRAZOLE; 5 HYDROXY 3 METHYL 5 TRIFLUOROMETHYL 4,5 DIHYDRO 1H 1 (4 METHOXYBENZOYL)PYRAZOLE; 5 HYDROXY 3 METHYL 5 TRIFLUOROMETHYL 4,5 DIHYDRO 1H 1 ACETYLPYRAZOLE; 5 HYDROXY 3 METHYL 5 TRIFLUOROMETHYL 4,5 DIHYDRO 1H 1 BENZOYLPYRAZOLE; 5 HYDROXY 3 METHYL 5 TRIFLUOROMETHYL 4,5 DIHYDRO 1H CARBALDEHYDE PYRAZOLE; 5 HYDROXY 3 METHYL 5 TRIFLUOROMETHYL 4,5 DIHYDRO 1H CARBOXYAMIDE PYRAZOLE; GLUTATHIONE; HYDROGEN PEROXIDE; IRON; NITROPRUSSIDE SODIUM; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON TRANSPORT; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTON TRANSPORT; RAT; SCAVENGING SYSTEM;

ANIMALS; FREE RADICAL SCAVENGERS; GLUTATHIONE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROSENCEPHALON; PYRAZOLES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STRUCTURE-ACTIVITY RELATIONSHIP;

RATTUS;

EID: 58449089595     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00346.x     Document Type: Article

References (39)

1. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and nonelectron transport chain sources. Antioxid Redox Signal 2005 7 : 1140 9.
2. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radical and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007 39 : 44 84.
3. Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Res 1998 32 : 117 31.
4. Genovese T, Mazzon E, Esposito E, Muià C, Di Paola R, Di Bella P et al. Role of endogenous glutathione in the secondary damage in experimental spinal cord injury in mice. Neurosci Lett 2007 423 : 41 6.
5. Arnold WP, Longneeker DE, Epstein RM. Photodegradation of sodium nitroprusside: biologic activity and cyanide release. Anesthesiology 1984 61 : 254 60.
6. Bates JN, Baker MT, Guerra R, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue. Biochem Pharmacol 1991 42 : S157 65.
7. Rauhala P, Khaldi A, Parameswarannay K, Chiueh CC. Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radic Biol Med 1998 24 : 1065 73.
8. Castellani RJ, Moreira PI, Liu G, Dobson J, Perry G, Smith MA et al. Iron: the redox-active center of oxidative stress in Alzheimer's disease. Neurochem Res 2007 32 : 1640 5.
9. Roy CN, Andrews NC. Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 2001 10 : 2181 6.
10. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002 5 : 291 309.
11. Facheris M, Beretta S, Ferrarese C. Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy? J Alzheimers Dis 2004 6 : 177 84.
12. Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M. Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 2005 31 : 81 93.
13. Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007 82 : 297 325.
14. Anderson CM, Halberg A, Brattsand R, Engman L, Persson J, Moldeus P et al. Diaryl telurides as inhibitors of lipid peroxidation in biological and chemical systems. Free Radic Res 1993 20 : 401 10.
15. Souza FR, Souza VT, Ratzlaff V, Borges LP, Oliveira MR, Bonacorso HG et al. Hypothermic and antipyretic effects of 3-methyl- and 3-phenyl-5-hydroxy-5- trichloromethyl-4,5-dihydro-1H-pyrazole-1-carboxyamides in mice. Eur J Pharmacol 2002 451 : 141 7.
16. Tabarelli Z, Rubin MA, Berlese DB, Sauzem PD, Missio TP, Teirxeira MV et al. Antinociceptive effect of novel pyrazolines in mice. Braz J Med Biol Res 2004 37 : 1531 40.
17. Prokopp CR, Rubin MA, Sauzem PD. A pyrazolyl-thiazole derivative causes antinoception in mice. Braz J Med Biol Res 2006 39 : 795 9.
18. 2-Adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone. Eur J Pharmacol 2004 496 : 93 7.
19. Costa D, Marques AP, Reis RL, Lima JLFC, Fernandes E. Inhibition of human neutrophil oxidative burst by pyrazolone derivatives. Free Radic Biol Med 2006 40 : 632 40.
20. Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem 2005 53 : 1841 56.
21. Bonacorso HG, Wentz AP, Lorega RV, Cechinel CA, Moraes TS, Coelho HS et al. Trifluoromethyl-containing pyrazolinyl (p-toluyl) sulfones: the synthesis and structure of promising antimicrobial agents. J Fluor Chem 2006 127 : 1066 72.
22. Martins MAP, Beck P, Machado P, Brondani S, Moura S, Zanatta L et al. Microwave-assisted of novel 5-trichloromethyl-4,5-dihydro-1H-1-pyrazole methyl esters under solvent free conditions. J Braz Chem Soc 2006 17 : 408 11.
23. Bonacorso HG, Oliveira MR, Costa MB. Regiospecific one-pot synthesis of new trifluoromethyl substituted heteroaryl pyrazolyl ketones. J Heterocycl Chem 2005 42 : 631 7.
24. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979 95 : 351 8.
25. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 1996 239 : 70 6.
26. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. Lebensm Wiss Technol 1995 28 : 25 30.
27. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959 82 : 70 7.
28. Aebi H. Catalase in vitro. Meth Enzymol 1984 105 : 121 6.
29. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972 247 : 3170 5.
30. Kefalas P, Kallithraka S, Parejo I, Makris DP. A comparative study on the in vitro antiradical efficiency and hydroxyl free radical scavenging activity in aged red wines. Food Sci Technol Res 2003 9 : 9383 7.
31. Verhagen JV, Haemen GRMM, Bast A. Nitric oxide radical scavenging by wines. J Agric Food Chem 1996 44 : 3733 4.
32. Graf E, Mahoney JR, Bryant RG, Eaton JW. Iron-catalyzed hydroxyl radical formation: stringent requirement for free iron coordination site. J Biol Chem 1984 259 : 3620 4.
33. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992 59 : 1609 23.
34. Mohanakumar KP, De Bartolomeis A, Wu RM, Yeh KJ, Sternberger LM, Peng SY et al. Ferrous-citrate complex and degeneration: evidence for free-radical formation and lipid peroxidation. Ann N Y Acad Sci 1994 738 : 392 9.
35. Villaño D, Pachón-Fernandez MS, Moyá ML. Radical scavenging ability of polyphenolic compounds towards DPPH free radical. Talanta 2007 71 : 230 5.
36. Foti MC, Daquino C, Geraci C. Electron-transfer reaction of cinnamic acids and their methyl esters with the DPPH radical in alcohol solutions. J Org Chem 2004 69 : 2309 14.
37. Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J. Agric Food Chem 2005 53 : 1841 56.
38. Mattson MP. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders. Ann N Y Acad Sci 2004 1012 : 37 50.
39. Kontush A, Schekatolina S. Vitamin E in neurodegenerative disorders Alzheimer's disease. Ann N Y Acad Sci 2004 1031 : 249 62.